The AI in healthcare industry focuses on leveraging artificial intelligence to enhance medical diagnostics, patient management, and overall operational efficiency in healthcare settings. Companies here, such as Aidoc and Viz.ai, create innovative solutions that utilize advanced algorithms to improve diagnosis accuracy and healthcare coordination. With a strong push towards integrating AI tools into existing workflows, this sector is positioned for significant growth. Insights indicate that as healthcare systems increasingly embrace technology, AI solutions will play a pivotal role in transforming how medical professionals make decisions and how patients receive care, potentially boosting patient outcomes dramatically.

Overall, the following companies showcase various sizes and specializations, primarily focusing on improving diagnostics and patient care through AI. Ranging from startups founded in recent years, like Paige (2018), to established firms such as DeepHealth (2015), many are headquartered in tech hubs like San Francisco and New York. Their collective offerings include AI platforms for clinical data analysis and AI tools for medical imaging, indicating a robust trend towards smarter healthcare applications.

Continue reading to discover the top AI in healthcare companies.

Top 28 AI In Healthcare Companies

1. Aidoc

• Website: aidoc.com
• Ownership type: Venture Capital
• Headquarters: New York, New York, United States (USA)
• Employee distribution: Israel 71%, United States (USA) 26%, Other 3%
• Latest funding: $30.0M, November 2023
• Founded year: 2016
• Headcount: 201-500
• LinkedIn: aidoc

Aidoc is a healthcare technology firm based in New York, founded in 2016. The company specializes in clinical AI solutions that enhance medical imaging and patient management. Aidoc's innovative algorithms are designed to improve diagnostic processes in hospitals and imaging centers, ultimately leading to better patient care and operational efficiency. Their proprietary aiOS™ platform integrates with existing healthcare IT infrastructures, facilitating real-time notifications and care coordination. Aidoc has achieved 17 FDA clearances for its algorithms, which cover various medical conditions, and has established partnerships with multiple healthcare organizations. The company has also recently secured $30 million in funding, underscoring its active role and relevance in the healthcare AI industry.

2. Viz.ai

• Website: viz.ai
• Ownership type: Venture Capital
• Headquarters: San Francisco, California, United States (USA)
• Latest funding: December 2023
• Founded year: 2016
• Headcount: 201-500
• LinkedIn: viz.ai

Viz.ai is a healthcare technology company based in San Francisco, California, founded in 2016. The company specializes in AI-powered solutions aimed at improving patient care coordination. Their product suite includes various applications designed to enhance diagnostic accuracy and streamline workflows for healthcare providers, particularly in hospitals and trauma centers. Viz.ai's technology leverages advanced algorithms to analyze medical imaging data, such as CT scans and EKGs, providing real-time insights that can accelerate diagnosis and treatment. The company has received FDA clearance for its algorithms, which underscores its commitment to regulatory compliance and clinical validation. By focusing on critical areas like neurovascular diseases, trauma care, and cardiovascular conditions, Viz.ai aims to close gaps in patient care and improve overall outcomes. Their solutions are integrated into existing healthcare workflows, making them accessible and practical for healthcare professionals.

3. Qure.ai

• Website: qure.ai
• Ownership type: Venture Capital
• Headquarters: New York, New York, United States (USA)
• Employee distribution: India 91%, United States (USA) 4%, United Kingdom (UK) 2%, Other 2%
• Latest funding: Series D, $65.0M, June 2024
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: qure.ai

Qure.ai is a healthcare technology company founded in 2016, based in New York, New York. The company focuses on developing artificial intelligence solutions aimed at improving medical diagnostics. Qure.ai's products are particularly geared towards enhancing the accuracy and speed of diagnoses for critical conditions such as tuberculosis, lung cancer, and stroke. Their AI tools are designed to support healthcare providers in making timely and informed decisions, thereby improving patient outcomes and expanding healthcare access worldwide. With a significant presence in India and operations in over 90 countries, Qure.ai has impacted more than 25 million lives. The company recently secured $65 million in Series D funding, reflecting its growth trajectory and the increasing demand for AI-driven healthcare solutions. Qure.ai's commitment to advancing public health through innovative technology positions it as a notable player in the healthcare AI industry.

4. Ada Health

• Website: ada.com
• Ownership type: Private Equity
• Headquarters: Berlin, Berlin, Germany
• Employee distribution: Germany 67%, United Kingdom (UK) 15%, United States (USA) 7%, Other 10%
• Latest funding: Series B, $30.0M, February 2022
• Founded year: 2011
• Headcount: 201-500
• LinkedIn: ada-health

Ada Health GmbH, based in Berlin, Germany, is a healthcare technology company founded in 2011. The firm specializes in AI-driven medical solutions, particularly through its symptom assessment app, which helps users understand and manage their health. The app is designed to provide quick, reliable assessments based on user-reported symptoms, leveraging a robust medical knowledge base developed by a team of doctors and scientists. Ada Health also offers enterprise solutions aimed at healthcare providers, enhancing patient outcomes and streamlining care processes. With a workforce of around 247 employees and a significant presence in multiple countries, Ada Health has established itself as a notable player in the healthcare technology sector. The company has attracted considerable investment, securing $30 million in its latest funding round in February 2022, which underscores its growth trajectory and the confidence investors have in its mission to improve healthcare access and quality through innovative technology.

5. Paige

• Website: paige.ai
• Ownership type: Private Equity
• Headquarters: New York, New York, United States (USA)
• Employee distribution: United States (USA) 73%, United Kingdom (UK) 10%, Canada 6%, Other 11%
• Latest funding: Series C, $125.0M, January 2021
• Founded year: 2018
• Headcount: 51-200
• LinkedIn: paige-ai

Paige is a healthcare technology company based in New York, specializing in digital pathology and artificial intelligence applications aimed at improving cancer diagnosis. Founded in 2018, the company has quickly established itself as a key player in the field, offering solutions that enhance diagnostic accuracy and streamline workflows for hospitals and laboratories. Their flagship products include the Paige Breast Suite and Paige Prostate Suite, which leverage extensive datasets to provide actionable insights for pathologists. Paige's platform is designed to digitize pathology laboratories, enabling more efficient and precise cancer detection. The company has received significant funding, totaling $125 million in its Series C round in January 2021, which supports its ongoing innovation and expansion efforts. With a global presence and a commitment to improving patient outcomes, Paige is positioned to make a substantial impact in the healthcare industry.

6. Innovaccer

• Website: innovaccer.com
• Ownership type: Venture Capital
• Headquarters: San Francisco, California, United States (USA)
• Employee distribution: India 87%, United States (USA) 13%
• Latest funding: January 2025
• Founded year: 2014
• Headcount: 1001-5000
• LinkedIn: innovaccer

Innovaccer Inc., founded in 2014 and based in San Francisco, California, is a healthcare technology firm that specializes in providing a comprehensive data activation platform and advanced analytics solutions. The company serves a variety of clients, including healthcare providers, payers, and life sciences organizations, with a mission to enhance patient care and operational efficiency through data-driven decision-making. Innovaccer's Health Cloud platform integrates healthcare data to facilitate patient-centered care and improve clinical and financial outcomes. Their AI capabilities are designed to automate repetitive tasks, streamline access to data, and uncover valuable insights, making them a significant player in the healthcare technology space. With a workforce of over 1,500 employees, primarily located in India and the United States, Innovaccer has established a strong presence in the industry, helping healthcare organizations achieve better outcomes and cost savings through their innovative solutions.

7. Mediktor

• Website: mediktor.com
• Ownership type: Venture Capital
• Headquarters: Viladecavalls, Catalonia, Spain
• Employee distribution: Spain 97%, United States (USA) 3%
• Latest funding: $12.8M, October 2021
• Founded year: 2011
• Headcount: 51-200
• LinkedIn: mediktor

Mediktor is a healthcare technology company based in Viladecavalls, Catalonia, Spain, founded in 2011. The company specializes in AI-driven solutions aimed at improving patient engagement and medical triage. Mediktor's offerings assist healthcare providers in enhancing patient care and streamlining medical processes, making them a valuable partner for organizations seeking to boost operational efficiency through innovative technology. With a workforce of around 63 employees, the company primarily serves clients in Spain, with a small presence in the United States. In 2021, Mediktor raised approximately $12.8 million in funding, reflecting strong investor interest in their AI solutions. The company has also expanded its capabilities through strategic acquisitions, such as Sensely, which positions them as a notable player in the AI healthcare sector.

8. nference

• Website: nference.com
• Ownership type: Venture Capital
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: India 90%, United States (USA) 9%
• Latest funding: December 2022
• Founded year: 2013
• Headcount: 201-500
• LinkedIn: nference

nference is a healthcare technology company based in Cambridge, Massachusetts, founded in 2013. The company specializes in AI-powered solutions aimed at clinical data analysis, serving healthcare providers and life sciences organizations. By transforming unstructured data into actionable insights, nference enhances patient outcomes and accelerates research efforts. The company has established long-term partnerships with premier healthcare centers, facilitating the connection of insights from de-identified data through a federated AI network. nference boasts a vast repository of clinical data, including over 1.4 billion clinical notes and millions of imaging studies, which it utilizes to empower research and improve treatment personalization. Their commitment to patient privacy and regulatory compliance is evident in their advanced de-identification algorithms and data quality validation frameworks. nference has also engaged in collaborations with notable institutions, such as the Mayo Clinic, to advance precision medicine initiatives. The company has raised significant capital from various investors, further supporting its growth and innovation in the healthcare sector.

9. Optellum

• Website: optellum.com
• Ownership type: Venture Capital
• Headquarters: Oxford, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 83%, United States (USA) 12%, France 4%
• Latest funding: Series A, $14.0M, September 2022
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: optellum

Optellum is a healthcare technology company based in Oxford, England, founded in 2016. The firm specializes in AI-driven solutions aimed at enhancing lung health and cancer diagnosis. Their flagship product, the Virtual Nodule Clinic, is recognized as the world's first AI-powered clinical decision support software for early lung cancer diagnosis. This platform helps clinicians identify and track at-risk patients, facilitating timely and optimal treatment decisions. Optellum has built a substantial real-world dataset of CT scans, which underpins its AI algorithms, allowing for improved accuracy in malignancy assessments and better patient outcomes. The company has also secured $14 million in Series A funding in September 2022, reflecting strong investor interest and support for its innovative approach to lung cancer management. Optellum collaborates with top hospitals and healthcare providers, contributing to advancements in lung cancer care through its technology.

10. Aitrics

• Website: aitrics.com
• Ownership type: Private Equity
• Headquarters: Gangnam, Seoul, South Korea
• Employee distribution: South Korea 100%
• Latest funding: Series B, $20.3M, March 2024
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: aitrics

Aitrics, founded in 2016 and based in Gangnam, Seoul, South Korea, is a private equity-backed healthcare technology firm that focuses on artificial intelligence solutions for medical applications. The company has developed AITRICS-VC (VitalCare), an AI-based product designed to assist healthcare providers in predicting patient deterioration and improving clinical workflows. Aitrics primarily serves healthcare institutions aiming to enhance patient care through innovative technology. The company has made strides in the industry, evidenced by its recent partnerships, including a memorandum of understanding with Philips Korea to develop a smart intensive care management solution. Aitrics has also received substantial funding, with a Series B round totaling approximately $20 million in March 2024, reflecting strong investor interest in its technology and potential. Their research efforts have been recognized in academic circles, with papers accepted at significant conferences, further establishing their credibility in the field.

11. SigTuple

• Website: sigtuple.com
• Ownership type: Venture Capital
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 100%
• Latest funding: Series C, $3.9M, August 2024
• Founded year: 2015
• Headcount: 51-200
• LinkedIn: sigtuple

SigTuple is a healthcare technology firm based in Bengaluru, India, founded in 2015. The company specializes in AI-driven medical diagnostics, offering products like Shonit, an automated blood smear slide analyzer, and Shrava, which automates urine sediment analysis. These solutions are aimed at healthcare providers and laboratories, improving the speed and accuracy of diagnostics. SigTuple has garnered attention for its innovative approach, combining artificial intelligence with robotics and cloud computing to streamline pathology processes. The company has also received funding, with its latest round being a Series C in August 2024, amounting to over $3.9 million. This financial backing supports their ongoing research and development efforts, positioning them as a notable player in the healthcare technology sector.

12. Pangaea Data

• Website: pangaeadata.ai
• Ownership type: Venture Capital
• Headquarters: South San Francisco, California, United States (USA)
• Employee distribution: United Kingdom (UK) 93%, United States (USA) 7%
• Latest funding: Seed, January 2021
• Founded year: 2017
• Headcount: 11-50
• LinkedIn: pangaeadata

Pangaea Data, founded in 2017 and based in South San Francisco, California, is a healthcare technology company that specializes in AI-driven solutions aimed at enhancing patient diagnosis and treatment. Their flagship product, the PALLUX platform, is designed to identify untreated and under-treated patients, thereby improving clinical outcomes. The company collaborates with healthcare providers and pharmaceutical firms to utilize existing patient data effectively. Pangaea Data has gained recognition for its innovative approach, being awarded 'Digital Solution of the Year' by the UK Government's Department for International Trade. This accolade reflects their commitment to addressing critical healthcare challenges through technology. With a small team of around 27 employees, Pangaea Data is making strides in the healthcare technology space, focusing on improving patient care and outcomes through advanced AI solutions.

13. Brainomix

• Website: brainomix.com
• Ownership type: Venture Capital
• Headquarters: Oxford, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 89%, United States (USA) 6%, Italy 3%, Other 3%
• Latest funding: Series C, $18.2M, March 2025
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: brainomix

Brainomix is a healthcare technology company based in Oxford, England, specializing in AI-powered imaging solutions aimed at improving medical diagnostics. Founded in 2010 as a spin-out from the University of Oxford, the company has developed a suite of products, including Brainomix 360 Stroke and e-ASPECTS, which enhance diagnostic capabilities for conditions such as stroke, lung disease, and cancer. Their solutions are designed to support healthcare providers in making faster and more accurate treatment decisions, ultimately improving patient outcomes. Brainomix has established a strong presence in the market, with its technology being adopted across various healthcare systems worldwide. The company has also secured significant funding, with its latest round being a Series C funding of approximately £18 million in March 2025, reflecting its growth potential and the increasing demand for AI solutions in healthcare.

14. PathAI

• Website: pathai.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 99%, Other 1%
• Latest funding: May 2024
• Founded year: 2016
• Headcount: 501-1000
• LinkedIn: pathai

PathAI, founded in 2016 and based in Boston, Massachusetts, is a healthcare technology company that specializes in AI-powered pathology solutions. The company develops advanced AI models designed to enhance the analysis of patient tissue samples. This technology supports biopharmaceutical companies and pathology laboratories in improving diagnostic accuracy and accelerating drug development processes. PathAI's offerings include the AI Sight digital pathology platform, which has received FDA 510(k) clearance, allowing it to be used for primary diagnosis in clinical settings. The company has built a robust network of over 450 pathologists and has contributed more than 15 million annotations to train and validate its AI models. This extensive data collection enables PathAI to deliver transformative tools that enhance the accuracy of diagnoses and facilitate the development of life-saving therapies. In 2021, PathAI secured $165 million in Series C funding, which has bolstered its research and development capabilities. The company has also expanded its services into clinical diagnostics through strategic acquisitions, further solidifying its role in the healthcare technology space.

15. Arkangel AI

• Website: arkangel.ai
• Ownership type: Venture Capital
• Headquarters: Hertford, England, United Kingdom (UK)
• Employee distribution: Colombia 82%, Panama 9%, Peru 9%
• Latest funding: Pre-seed, $75,000, April 2022
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: arkangel-ai

Arkangel AI, founded in 2019 and based in Hertford, England, is a healthcare technology firm that leverages artificial intelligence to enhance healthcare outcomes. The company specializes in creating AI algorithms and solutions designed to improve patient care and operational efficiency for healthcare institutions. Their offerings include automated tools for medical record summarization, clinical research, and patient care planning, addressing significant challenges faced by healthcare providers. Arkangel AI has received pre-seed funding of $75,000 in April 2022, indicating early-stage investment interest. The company has also collaborated with various healthcare institutions, showcasing its commitment to transforming healthcare delivery through innovative AI solutions.

16. Blackford

• Website: blackfordanalysis.com
• Ownership type: Corporate
• Headquarters: Edinburgh, Scotland, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 95%, United States (USA) 3%, Other 2%
• Latest funding: January 2023
• Founded year: 2009
• Headcount: 51-200
• LinkedIn: blackford-analysis-ltd

Blackford Analysis, founded in 2009 and based in Edinburgh, Scotland, is a healthcare technology company that focuses on artificial intelligence solutions for medical imaging. The company has developed a centralized platform that simplifies the management of multiple AI applications, allowing healthcare providers to enhance diagnostic confidence and streamline their workflows. Blackford serves a wide range of clients, including radiologists, non-radiology clinicians, IT departments, and medical research groups, all aiming to improve patient outcomes through advanced technology. With a portfolio that includes over 135 contracted AI solutions from more than 50 partner vendors, Blackford is well-positioned to support various clinical and operational needs. Their professional services, which include consultancy and ongoing support, further demonstrate their commitment to helping healthcare institutions effectively implement AI solutions. Blackford's strategic partnerships with regional solution providers and blue-chip companies highlight their active role in the healthcare technology sector.

17. CitiusTech

• Website: citiustech.com
• Ownership type: Private Equity
• Headquarters: United States (USA)
• Employee distribution: India 89%, United States (USA) 10%
• Latest funding: October 2022
• Founded year: 2005
• Headcount: 5001-10000
• LinkedIn: citiustech

CitiusTech is a healthcare technology company founded in 2005, headquartered in the United States. With a workforce of nearly 6,000 employees, the company provides a wide array of services aimed at improving healthcare delivery through technology. Their offerings include data management, consulting, and digital engineering, catering to a variety of clients such as MedTech firms, payers, and healthcare providers. CitiusTech is particularly focused on digital transformation, utilizing advanced technology solutions to enhance operational efficiency and patient outcomes. The company has made significant strides in integrating AI into their services, with a dedicated focus on AI and analytics across multiple healthcare sectors. Their product suite includes solutions for clinical decision support, patient engagement, and revenue cycle management, all designed to optimize healthcare operations. CitiusTech's commitment to innovation is evident in their recent developments, including the industry's first Generative HEDIS solution, which showcases their proactive approach to harnessing AI in healthcare.

18. care.ai

• Website: care.ai
• Ownership type: Corporate
• Headquarters: Orlando, Florida, United States (USA)
• Employee distribution: United States (USA) 98%, China 2%
• Latest funding: August 2024
• Founded year: 2018
• Headcount: 51-200
• LinkedIn: careai

care.ai, founded in 2018 and based in Orlando, Florida, is a healthcare technology firm that specializes in AI-driven solutions aimed at enhancing patient monitoring and operational efficiency. The company provides a range of services, including virtual care, patient protocol monitoring, and the development of smart care environments. Their technology is designed to support hospitals, assisted living centers, and home care providers, helping them to optimize patient experiences and streamline operations. care.ai has deployed its solutions in over 1,000 facilities, showcasing its impact on the healthcare industry. The company is committed to transforming healthcare delivery through its ambiently aware AI platform, which continuously learns and adapts to improve care processes and patient safety.

19. Oxford Immune Algorithmics

• Website: immunealgorithmics.com
• Ownership type: Venture Capital
• Headquarters: Reading, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 82%, India 12%, United Arab Emirates 6%
• Latest funding: Seed, $7.1M, April 2021
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: oxford-immune-algorithmics

Oxford Immune Algorithmics, founded in 2018 and based in Reading, England, is a healthcare technology company that specializes in artificial intelligence-driven solutions for medical diagnostics. The company is known for its flagship product, Algocyte®, which offers precision diagnostics and predictive analytics to healthcare providers and patients. This innovative platform aims to tackle critical health challenges, including cancer, antibiotic resistance, and inflammation, by utilizing advanced AI techniques such as causal predictive and generative AI. The firm has received significant venture capital funding, amounting to £7.12 million in its last funding round in April 2021, which underscores its potential in the healthcare technology space. With a team that includes experts from top institutions like Oxford and Cambridge, Oxford Immune Algorithmics is committed to improving healthcare outcomes through responsible and clinically validated tools. Their approach combines mechatronics, nanotechnology, and biochemical imaging, creating a comprehensive solution for remote health monitoring and early disease detection.

20. Quinten

• Website: quinten.ai
• Ownership type: Private
• Headquarters: Paris, Île-De-France, France
• Employee distribution: France 80%, Morocco 20%
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: quinten

Quinten, founded in 2008 and based in Paris, is a private company specializing in data science and AI solutions. With a workforce of around 51-200 employees, Quinten operates primarily in healthcare, finance, and education. Their healthcare division, Quinten Health, focuses on developing tools that enhance decision-making and operational efficiency for healthcare professionals. Notable products include PharmIA, which aids in medical decision-making, and Niel’s Medical Device, which likely supports medical device analytics. Quinten also has a DataLab that features AliBERT, a model tailored for biomedical language processing. The company serves a range of clients, including healthcare professionals and financial institutions, indicating a strong foothold in the healthcare sector. Quinten's approach emphasizes the use of real-world data and interpretable AI, which are critical for effective healthcare applications.

21. IDx

• Website: eyediagnosis.net
• Ownership type: Private
• Headquarters: Coralville, Iowa, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: idxtechnologiesinc

IDx, also known as Digital Diagnostics, is a healthcare technology firm based in Coralville, Iowa. Founded in 2010, the company specializes in AI-driven diagnostic solutions aimed at improving patient care. Their primary product, LumineticsCore™, is designed to diagnose diabetic retinopathy at the point-of-care, allowing healthcare providers to deliver immediate results without the need for a physician's evaluation. This capability not only streamlines the diagnostic process but also enhances patient access to necessary eye care services. IDx has made significant strides in the industry by being the first to receive FDA clearance for an autonomous AI diagnostic system, setting a precedent for future innovations in medical AI. The company is dedicated to ethical AI practices and aims to reduce healthcare disparities by making quality care more accessible and affordable.

22. DeepHealth

• Website: deephealth.com
• Ownership type: Private
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: Netherlands 41%, United States (USA) 30%, India 12%, Other 17%
• Founded year: 2015
• Headcount: 201-500
• LinkedIn: deephealthai

DeepHealth is a healthcare technology company based in Cambridge, Massachusetts, founded in 2015. The company specializes in AI-powered health informatics, providing advanced diagnostic tools aimed at enhancing cancer detection and improving operational efficiency in radiology. Their product suite includes the Diagnostics Suite, eRAD, and various population health solutions such as Lung Check and Smart Mammo. DeepHealth primarily serves healthcare providers and institutions, helping them to enhance patient care through innovative technology. The company manages over 2 million studies annually, showcasing its significant impact in the field. With a workforce distributed across several countries, including the Netherlands and the United States, DeepHealth is positioned to influence the global healthcare landscape through its AI-driven solutions.

23. Arterys (Acquired by Tempus AI)

• Website: arterys.com
• Ownership type: Corporate
• Headquarters: San Francisco, California, United States (USA)
• Employee distribution: United States (USA) 69%, Canada 31%
• Latest funding: February 2023
• Founded year: 2013
• Headcount: 51-200
• LinkedIn: arterys

Arterys is a healthcare technology company based in San Francisco, California, specializing in medical imaging and artificial intelligence. Founded in 2013, the company has developed a platform that integrates AI clinical applications into existing healthcare workflows, significantly enhancing diagnostic accuracy and efficiency for healthcare providers and researchers. With a focus on improving the physician experience and patient outcomes, Arterys' solutions are designed to seamlessly fit into existing PACS or EHR systems. In February 2023, Arterys was acquired by Tempus AI, a company dedicated to advancing precision medicine through data and AI applications in healthcare. This acquisition allows Arterys to expand its reach and capabilities, integrating its imaging solutions into Tempus' broader offerings, which now include comprehensive patient views that incorporate radiology scans. The company operates primarily in the United States and Canada, with a workforce of around 51-200 employees.

24. GE Healthcare Partners

• Website: gehealthcarepartners.com
• Ownership type: Private
• Headquarters: Chicago, Illinois, United States (USA)
• Founded year: 2012
• Headcount: 201-500
• LinkedIn: gehealthcarepartners

GE Healthcare Partners, based in Chicago, Illinois, is a healthcare technology company that specializes in providing innovative solutions aimed at enhancing operational efficiency and patient care. Founded in 2012, the company has developed tools such as Command Center Software, which leverages AI to facilitate real-time decision-making and improve care coordination. With a workforce of approximately 184 employees, GE Healthcare Partners draws on over a century of industry experience to serve healthcare organizations globally. Their focus on precision care and the integration of AI into healthcare workflows underscores their commitment to transforming healthcare delivery and improving outcomes for patients and providers alike.

25. TeraRecon, Inc.

• Website: terarecon.com
• Ownership type: Corporate
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 68%, India 14%, Italy 5%, Other 13%
• Latest funding: November 2021
• Founded year: 1997
• Headcount: 51-200
• LinkedIn: terarecon-inc-

TeraRecon, Inc. is a healthcare technology company based in Durham, North Carolina, specializing in advanced visualization and artificial intelligence solutions for medical imaging. Established in 1997, TeraRecon has developed a range of software products that enhance the analysis and interpretation of medical images, primarily serving hospitals and imaging centers. Their solutions aim to streamline clinical workflows and improve patient care outcomes. TeraRecon has made significant strides in the industry, launching innovative platforms like EnvoyAI, which serves as a marketplace for medical imaging AI applications, and the Northstar AI Results Explorer, which is designed to facilitate AI-driven insights in medical imaging. The company has a global presence, with active installations in over 74 countries and a commitment to continuous innovation in the field of medical imaging. TeraRecon's recent integration with ConcertAI further highlights its focus on advancing clinical AI solutions and enhancing precision oncology research.

26. AI for Health Hub

• Website: yesilscience.com
• Ownership type: Private
• Headquarters: Istanbul, İstanbul, Turkey
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: yesil-society

AI for Health Hub, also known as Yesil Science, is a private health technology firm based in Istanbul, Turkey, founded in 2016. The company specializes in creating AI-driven healthcare solutions, which include software development for health applications, mobile health tools, and comprehensive health data analysis. Yesil Science serves a range of clients, including healthcare providers and patients, by providing innovative tools designed to improve patient care and optimize healthcare operations. Their portfolio features over 15 AI-driven health products, addressing various medical specialties such as cardiology, oncology, and mental health. The company has established itself as a player in the health tech industry, focusing on scalable solutions that adapt to the evolving needs of healthcare.

27. Luye Medical Group

• Website: luyemedical.com
• Ownership type: Private
• Headquarters: Singapore
• Employee distribution: China 76%, Singapore 20%, Hong Kong S.A.R 5%
• Founded year: 2015
• Headcount: 1001-5000
• LinkedIn: luye-medicals-group-pte-ltd

Luye Medical Group, founded in 2015 and based in Singapore, is a private healthcare technology company. The firm specializes in providing innovative healthcare services and artificial intelligence solutions tailored for healthcare providers and institutions. Their primary goal is to enhance patient care and operational efficiency through advanced technology. With a significant presence in China, Singapore, and Hong Kong, Luye Medical is actively involved in addressing the challenges faced by medical professionals by integrating AI into healthcare practices. The company has not reported any funding, indicating a self-sustained operational model thus far.

28. Ultromics

• Website: ultromics.com
• Ownership type: Venture Capital
• Headquarters: Oxford, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 89%, United States (USA) 11%
• Latest funding: Series B, $32.8M, August 2021
• Founded year: 2017
• Headcount: 51-200
• LinkedIn: ultromics

Ultromics is a healthcare technology company based in Oxford, England, founded in 2017. The company specializes in AI-driven solutions for heart failure detection, particularly focusing on heart failure with preserved ejection fraction (HFpEF). Their flagship product, EchoGo Heart Failure, utilizes deep learning algorithms to analyze echocardiograms, providing healthcare providers with accurate diagnostics that can significantly improve patient outcomes. Ultromics collaborates with prominent medical institutions, including the Mayo Clinic, to validate and enhance their technology. The company has raised over $50 million in funding, with notable investors such as Google Ventures and Optum, reflecting strong market interest in their innovative approach to cardiovascular care. Ultromics is committed to addressing the challenges of heart failure diagnosis, aiming to streamline workflows and reduce costs associated with misdiagnosis.

AI In Healthcare Insights: Key Companies

Want to Find More AI In Healthcare Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!